PARP16
Basic information
Region (hg38): 15:65234460-65300618
Previous symbols: [ "C15orf30" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (45 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PARP16 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001316943.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 45 | 45 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 45 | 1 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PARP16 | protein_coding | protein_coding | ENST00000261888 | 6 | 66159 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.99e-10 | 0.0868 | 125703 | 0 | 45 | 125748 | 0.000179 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.367 | 167 | 181 | 0.923 | 0.00000961 | 2101 |
| Missense in Polyphen | 54 | 56.39 | 0.95762 | 628 | ||
| Synonymous | 0.0142 | 77 | 77.2 | 0.998 | 0.00000435 | 635 |
| Loss of Function | 0.139 | 15 | 15.6 | 0.962 | 9.44e-7 | 164 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000496 | 0.000496 |
| Ashkenazi Jewish | 0.000199 | 0.000198 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.000278 | 0.000277 |
| European (Non-Finnish) | 0.000106 | 0.000105 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.000229 | 0.000229 |
| Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Intracellular mono-ADP-ribosyltransferase that may play a role in different processes through the mono-ADP-ribosylation of proteins involved in those processes (PubMed:23103912, PubMed:22701565). May play a role in the unfolded protein response (UPR), by ADP-ribosylating and activating EIF2AK3 and ERN1, two important UPR effectors (PubMed:23103912). May also mediate mono- ADP-ribosylation of karyopherin KPNB1 a nuclear import factor (PubMed:22701565). May not modify proteins on arginine, cysteine or glutamate residues compared to other mono-ADP- ribosyltransferases (PubMed:22701565). {ECO:0000269|PubMed:22701565, ECO:0000269|PubMed:23103912}.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.830
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.91
Haploinsufficiency Scores
- pHI
- 0.234
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.652
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Parp16
- Phenotype
Gene ontology
- Biological process
- protein ADP-ribosylation;endoplasmic reticulum unfolded protein response;NAD biosynthesis via nicotinamide riboside salvage pathway;IRE1-mediated unfolded protein response;negative regulation of cell death;protein auto-ADP-ribosylation;positive regulation of protein serine/threonine kinase activity;cellular response to leukemia inhibitory factor
- Cellular component
- nuclear envelope;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;membrane;integral component of membrane;endoplasmic reticulum tubular network
- Molecular function
- NAD+ ADP-ribosyltransferase activity;protein binding;kinase binding;protein serine/threonine kinase activator activity